Laura Delano: How Big Pharma Created the Mental Health Crisis

Overview

Laura Delano argues that mainstream psychiatry and “Big Pharma” have helped create—and perpetuate—a mental health crisis by reframing human distress as an incurable, brain-based disease. In this view, treatment is managed primarily through long-term medication. She challenges the popular “chemical imbalance” explanation for depression and other diagnoses, arguing it has never been scientifically proven and is conceptually undefined (there’s no clear way to measure what “balance” means).

Delano also disputes the assumption that mental illness symptoms reflect a stable biological pathology. Instead, she suggests that suffering often makes sense as a response to lived circumstances and emotional pain—an area she says psychiatric systems largely prevent clinicians from addressing.

Core critiques of the psychiatric/medication model

• The “chemical imbalance” narrative is unproven and misleading

  • Delano highlights surveys indicating many Americans still believe it.
  • She cites review/umbrella-review claims (as discussed in the video) arguing that the theory lacks proof.

• Diagnoses rely on subjective observation

  • She argues psychiatric labels (including severe conditions) typically lack objective biological tests.
  • Clinician judgment can be influenced by personal or contextual factors.

• Long-term medication use lacks evidence and accountability

  • Delano claims drug approval is based on short trials, while long-term safety and efficacy remain less established.
  • She also argues that combination prescribing (polypharmacy) is rarely studied as such.

• Medicalization can reduce agency

  • Her central theme is that these frameworks encourage patients to see themselves as incapable of self-determination—“at the mercy of faulty brain chemistry.”
  • She argues this undermines responsibility and meaningful change.

Her personal pathway (as evidence for the critique)

Delano describes early distress beginning around age 13, including an intense dissociative/out-of-reality experience. This was followed by escalating self-harm and “acting out.” Her parents, motivated by love, sought help through therapy and then psychiatry.

At 14, she was told she had bipolar disorder and that it would be lifelong. She says medications were presented as the solution without evidence or objective testing.

Later, while attending Harvard and deteriorating further (drinking and using drugs), she re-entered psychiatry seeking relief. She describes a polypharmacy regimen including antidepressants, mood stabilizers, antipsychotics, benzodiazepines, and other drugs. She attributes harms to this period, including:

• Physical side effects

  • Digestive problems
  • Major weight gain
  • Chronic aches/pains
  • Skin/hair/nail issues

• Cognitive/emotional effects

  • “Numbing”
  • Dissociation
  • Memory and comprehension decline
  • “Zombie-like” functioning

• Loss of identity and relationships

  • She says medication impaired connection with family, friends, spirituality/God
  • She also describes difficulty regaining sexuality and “erotic life force”

Delano argues that psychiatry can convert worsening symptoms into “proof” that illness is progressing rather than evidence that treatment is harming the person. She repeatedly emphasizes “medication spellbinding,” describing how drug effects can impair the critical thinking needed to question the treatment itself.

Broader societal concerns she raises

• Mental health crisis framing vs. treatment failure

  • Delano challenges claims that suicide and mental health problems reflect insufficient care.
  • She argues it may instead be that treatment—rather than lack of it—is contributing.

• Medication side effects and risks (including sex and violence concerns)

  • PSSD (post-SSRI sexual dysfunction): she points to a movement describing persistent sexual dysfunction after stopping SSRIs.
  • Suicidal/homicidal ideation warnings: she argues antidepressants are sometimes labeled with risks such as increased suicidal or homicidal ideation, implying these risks are not treated with adequate transparency.
  • Speculated link to mass shootings: she raises the idea that SSRIs may be linked to mass shootings, while claiming the topic is treated as unacceptable and not investigated openly.

• Trauma and harm through newer “treatment-resistant” pathways

  • She describes “treatment resistance” as a concept that can enable continued medical escalation, including device-based interventions.
  • Examples she mentions include deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS), as well as continued use of ECT.
  • Her broader claim is that desperation can lead people to accept extreme interventions without sufficient emphasis on alternatives or potential harms.

Recovery and what replaced the medicalized identity

Delano describes a turning point around age 27 (2010), when she quit drinking but remained severely unwell. She recounts interactions with psychiatric authority that included coercive elements (involuntary holds and forced medication), which she says helped her question the legitimacy of psychiatric power and the diagnosis framework.

She later read Robert Whitaker’s Anatomy of an Epidemic, which she says shifted her belief from “treatment-resistant illness” to “the treatment might be making people sicker.”

She describes a slow, difficult withdrawal process from multiple psych medications (she says she removed five drugs within about six months, requiring years of tapering in general terms). She credits stabilizers during recovery such as supportive housing from family, plus AA and community connection.

Over time, she describes a trajectory of:

• Year 1: “extreme hell”
• Years 1–3: gradually improving
• Around year 3: feeling “come alive again”

She says she regained cognition, connection to others, sexuality, and her sense of self—while still acknowledging she can experience intense emotions and stress.

Main message / advocacy

Delano’s overarching argument is not that all psychiatric care is inherently malevolent. Instead, she claims the dominant system is structured like a business model that profits from fear, long-term dependence, and reframing suffering as lifelong disease.

She promotes:

• informed consent
• reading drug labels
• understanding research limitations
• considering social/mutual-aid forms of support rather than defaulting reflexively to medication

She also describes starting a nonprofit—InnerCompass Initiative—to provide educational resources on psychiatric drug research and marketing, DSM history, and how to read/understand medications. She emphasizes mutual aid and peer support as a radical alternative.

Presenters or contributors

• Tucker (host/interviewer)
• Laura Delano (guest/interviewee)